Essential Medicines for Children

  title={Essential Medicines for Children},
  author={Kalle Hoppu},
  journal={Clinical Pharmacology \& Therapeutics},
  • K. Hoppu
  • Published 1 June 2017
  • Medicine, Political Science
  • Clinical Pharmacology & Therapeutics
The World Health Organization (WHO) defines Essential Medicines as those that satisfy the priority healthcare needs of the population. The right to essential medicines has been considered an important component of the right to health. In the name of equity, children should also have access to appropriate, available, affordable, and quality essential medicines they need, but children's essential medicines are too often missing. 

Access to age-appropriate essential medicines: a retrospective survey of compounding of medicines for children in hospitals in Nigeria and implications for policy development

The study recommends policy expansion through a three-pronged approach to improving access: increased supply through facilitated importation/accelerated product registration, or in-country manufacturing; rational drug use including therapeutic substitution, and establishment of a national formulary for compounding.

Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study

Most EMLc medicines for diseases common in the three countries had supporting evidence, which was closely associated with approval, whereas a substantial number of medicines for NIDs were unapproved in theThree countries, regardless of whether they had supportingevidence.

A comparison of five paediatric dosing guidelines for antibiotics

The pharmacokinetic, pharmacodynamic and clinical evidence supporting paediatric antibiotic dosing, particularly on total doses and on age or weight dosing bands, needs to be improved.

Drugs for Children

  • S. Ito
  • Medicine, Psychology
    Clinical pharmacology and therapeutics
  • 2017
The juncture of pediatric pharmacology and global child health represents an emerging field of clinical pharmacology illuminating a crucial societal need on a global scale for safer and more effective pediatric drug therapy.

Collaborative partnerships as a solution for poor access to essential antimicrobial medicines: what can we learn from the chlorhexidine gel example?

This poster presents a probabilistic procedure to characterize the immune response of the central nervous system to treat central giant cell granuloma.

Availability, Management and Use of Priority Life-Saving Medicines for Under-Five Children in Two Health Districts in Senegal: A Cross-Sectional Study

The results show that access to priority life-saving medicines for children remains a challenge and measures to be taken should include improving the distribution channels and training of health professionals.

Key Challenges in the Search for Innovative Drug Treatments for Special Populations. Converging Needs in Neonatology, Pediatrics, and Medical Genetics

Unless a specific action plan is urgently developed, there will be a continuing gap in availability of the essential expertise needed to address treatment challenges in special patient populations such as neonates, patients suffering from rare or neglected diseases, and children of all ages.

Audit of Antibiotic Prescription in Suspected Neonatal Sepsis at an Indian Tertiary Care Hospital

The rationality of antibacterial drug usage in suspected cases of neonatal sepsis was followed the majority of times, leading to better patient care and outcome, according to this study.

Drug Prescribing Patterns at Public Health Centres in Greater Wad Medani Locality, Gezira State, Sudan (2015)

Prescribing from essential drug list and prescribing by generic names need to be encouraged and clear criteria to control antibiotic prescription are needed.

Children's palliative care in low- and middle-income countries

It is concluded that while much has been achieved in palliative care for adults, less attention has been devoted to the education, clinical practice, funding and research needed to ensure children and young people receive the palliatives care they need.



Essential Medicines for the Whole World

  • M. Reidenberg
  • Medicine, Political Science
    Clinical pharmacology and therapeutics
  • 2007
The concept is that medicines needed to satisfy the priority health‐care needs of a population should be made available at all times to everyone in the population within the context of a functioning health-care system.

Essential medicines for children

Data from country surveys show that access to essential medicines for children is still generally poor; much more work is needed.

World Health Organization Program for the Selection and Use of Essential Medicines

  • M. Reidenberg
  • Medicine, Political Science
    Clinical pharmacology and therapeutics
  • 2007
With all societies dealing with the rising cost of medical care and having to make choices, the concept of essential medicines is a relevant to all now as it was to countries with limited resources when the WHO program started in 1975.

Putting the priorities first: medicines for maternal and child health.

  • S. Hill
  • Medicine, Political Science
    Bulletin of the World Health Organization
  • 2012
Countries that are working to meet the United Nations Millennium Development Goals related to maternal and child survival, however, need additional support to ensure access to medicines that will help achieve the specified tar-gets.

Global aspects of drug development.

The Essential Medicines List for children first made available in 2008 serves as an example of the many tools available from WHO to improve children's access to the medicines they need.

Priority Medicines for Maternal and Child Health: A Global Survey of National Essential Medicines Lists

It is suggested that countries need to urgently amend their lists to provide all priority medicines as part of the efforts to improve maternal and child health.

The Essential Medicines List for a Global Patient Population

The role, audience, and contents of the global Essential Medicines List (EML) are reviewed, and the advocacy role of the EML for both drug procurement and development of quality‐assured products is described.

The selection and use of essential medicines. Report of the WHO expert committee, 2005 (including the 14th model list of essential medicines).

  • Medicine
    World Health Organization technical report series
  • 2006
This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model List of Essential Medicines. The first part contains a summary of the Committee's

Availability of five essential medicines for children in public health facilities in India: A snapshot survey

The availability of essential medicines for children in public health facilities of India is not satisfactory and needs to be improved.

The selection and use of essential medicines.

This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model List of Essential Medicines, including its recommendations.